In conclusion, low-dose aCD3 therapy in combination with oral delivery of L. lactis bacteria secreting PINS with IL-10 can bypass autoimmune recurrence in syngeneic islet recipients with long-duration T1D. This evidence concerns the gene IL10 and type 1 diabetes mellitus.